Skip to content

Comparison of the effect of Ganoderma lucidium and Kambucha on blood sugar in patients with type 2 diabetes

Comparison of the effect of Ganoderma lucidium and Kambucha on blood sugar in patients with type 2 diabetes

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190919044819N3
Enrollment
75
Registered
2020-10-26
Start date
2021-03-19
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with type 2 diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group1: In addition to the previous oral antidiabetic drugs, the first group can consume 1 gram per day in the first week, 2 grams per day in the second week, and from th

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: With type 2 diabetes with fasting blood sugar between 140 and 200 mg / dL Be over 18 years old Assessment tools to fully understand the instructions. Read and sign informed consent. Not using of immunosuppressive drugs(Kambucha drink can activate the immune system.) Not using Anticoagulant therapy Not having neuropsychological, cognitive diseases Not having cardiac diseases Not having renal diseases Not having Allergic history Not having retinopathy Not having Creatinine above 1.2 mg / dL Not having Triglycerides above 40 mg / dL

Exclusion criteria

Exclusion criteria: Insulin consumption Is pregnant or suspected pregnancy Participation in another study that could affect results

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: Fasting blood sugar will be measured and analyzed at the first visit and also after the end of 6 weeks of treatment. Method of measurement: Glucometer.;Glucose two hours after a meal. Timepoint: Glucose two hours after a meal will be measured and analyzed at the first visit and also after the end of 6 weeks of treatment. Method of measurement: Glucometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeili Yekefallah

Qazvin University of Medical Sciences

Leili_fallah@yahoo.com+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026